Few flu hotspots at global and national levels
Over the 2 weeks that closed out August, flu activity in the world remained at low levels, with H3N2 as the predominant strain and 2009 pandemic H1N1 (pH1N1) and influenza B circulating in many countries as well, the World Health Organization (WHO) said today.
The two main hot spots were Australia, where pH1N1 activity increased, and New Zealand, which reported that H3N2 and influenza B activity is still high. The Southern Hemisphere's flu season typically runs from May through October.
The WHO said flu activity remained low in Europe, North America, and Asia.
In the United States, flu levels remained well below seasonal baselines, according to an update today from the Centers for Disease Control and Prevention (CDC). Reports of sporadic outbreaks are starting to appear in the media, however, and earlier this week Los Angeles County reported an uptick in activity, mainly from pH1N1.
No new variant H3N2 (H3N2v) cases were reported, keeping the total at 18. The most recent case was reported last week by Michigan, which has now detected two of the novel infections.
The CDC reported three more pediatric flu deaths, which raised the total for the 2012-13 season to 164. The newly reported fatalities all occurred in March; one was linked to H3N2, and the other two involved influenza B viruses.
Sep 13 WHO global flu virologic update
Sep 13 CDC weekly influenza update
Sep 11 CIDRAP News scan "Los Angeles reports uptick in flu cases"
ECDC confirms three H7N7 cases in Italian poultry workers
Three poultry workers in the Italian region beset with outbreaks of highly pathogenic H7N7 avian flu in poultry have contracted H7N7 conjunctivitis, the European Centre for Disease Prevention and Control (ECDC) confirmed today.
The Emilia Romagna region in northern Italy has now had six outbreaks in birds, Bloomberg News reported this week.
One of the H7N7 cases was in a 51-year-old who developed conjunctivitis in one eye on Aug 30. He had recovered by Sep 3. He was isolated at home, and four family members are under 10-day active surveillance for disease.
In addition, a 46-year-old man developed bilateral conjunctivitis and was placed in isolation to prevent disease spread. Details on the third man's case are sketchy, but he was also placed in isolation. The three men all worked on the same poultry farm.
One of these cases was reported by the media on Sep 2, but the reports did not specify his age. The ECDC said in today's report, "Active surveillance has been implemented to all workers exposed to sick animals and their close contacts. The same applies to workers involved in culling operations."
Bloomberg News reported on Sep 11 that, since Aug 28, the Emilia Romagna had seen three more H7N7 poultry outbreaks, bringing the region's outbreak total to six. One of the new outbreaks had previously been reported by the World Organization for Animal Health (OIE) on Aug 28.
Two of the new outbreaks, including the one already confirmed by the OIE, were on commercial farms owned by a poultry company affected by a previous outbreak, while the third involved a rural backyard flock, according to the report. Almost 220,000 birds were culled in the three outbreaks to prevent disease spread, Bloomberg reported. More than 730,000 were killed in the prior three outbreaks, according to the story.
Sep 13 ECDC report
Sep 11 Bloomberg story
Study affirms test-negative design for gauging flu vaccine effectiveness
The test-negative design (TND) for assessing influenza vaccine effectiveness, an increasingly common method, stacks up well against randomized controlled trials (RCTs), the "gold standard" approach, according to an analysis published yesterday in Eurosurveillance.
The TND involves comparing the vaccination status of patients who test positive or negative for flu after seeking medical care for a flu-like illness. It is a convenient and relatively low-cost approach, says the report, because it does not require recruitment of healthy controls, the procedure typically used in case-control studies.
In the study, researchers from two Canadian institutions and MedImmune Inc., the manufacturer of live attenuated influenza vaccine (LAIV), aimed to test the "core assumption" of TND: that the vaccine has no effect on other, non-targeted pathogens that cause flu-like illnesses.
They used data from four large RCTs of LAIV to compare RCT estimates of flu vaccine effectiveness with estimates from the TND. For a further test, they applied the TND to data from two RCTs of the efficacy of humanized monoclonal antibody for preventing hospitalization in respiratory syncytial virus (RSV) cases.
The results: "Efficacy estimates and their confidence intervals were virtually identical for per-protocol RCT versus TND analyses of LAIV and also for RSV monoclonal antibody," the report says. The results also showed that LAIV and the RSV antibody did not affect the risk of diseases caused by non-targeted pathogens.
"This study validates the core assumption of the TND approach for influenza vaccine efficacy estimation and confirms the accuracy and precision of its estimates compared to the gold standard of classic per-protocol RCT analysis of the same data sets," the authors conclude.
Sep 12 Eurosurveillance report
Kids with neurologic conditions had low seasonal flu vaccination rates
Although they are at greater risk for poor influenza outcomes, flu vaccination coverage of children with neurologic or neurodevelopmental (NND) conditions was similar to that in the general pediatric population, according to a report today in Morbidity and Mortality Weekly Report (MMWR).
Working with Family Voices and the American Academy of Pediatrics, researchers from the Centers for Disease Control and Prevention (CDC) surveyed parents and physicians during the 2011-12 influenza season. Overall, parents of children with high-risk conditions completed 1,940 surveys, and flu vaccination rates ranged from 41% for children with metabolic conditions to 78% for those with chronic lung disease.
Of the 1,005 children with NND conditions, parents reported that 50% of children were vaccinated or had a vaccine appointment scheduled. Vaccination rates were low both for children with intellectual disability (52%) and for those with epilepsy (59%).
In addition, physician recognition of high-risk conditions was low for intellectual disability (46%) and epilepsy (52%). But physicians who care for children with NND conditions were statistically more likely than other physicians to identify most NND conditions as risk factors for influenza complications, the report said.
Sep 13 MMWR report